KPP Advisory Services’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,151
| Closed | -$260K | – | 293 |
|
|
2024
Q4 | $260K | Sell |
8,151
-130
| -2% | -$4.15K | 0.06% | 214 |
|
|
2024
Q3 | $239K | Sell |
8,281
-2,985
| -26% | -$86.1K | 0.06% | 225 |
|
|
2024
Q2 | $432K | Sell |
11,266
-130
| -1% | -$4.99K | 0.11% | 145 |
|
|
2024
Q1 | $670K | Buy |
11,396
+200
| +2% | +$11.8K | 0.18% | 103 |
|
|
2023
Q4 | $670K | Buy |
11,196
+1,675
| +18% | +$100K | 0.59% | 44 |
|
|
2023
Q3 | $362K | Buy |
+9,521
| New | +$362K | 0.12% | 127 |
|